October 2017
On the Cover
Laser treatment in children
October 03, 2017By Karen Appold
Laser treatments can have a significant positive impact on a child’s wellbeing. Adopt techniques to minimize anxiety for children. Some conditions can be treated when the child is older.
In this issue
Columns
The weightless word challenge
September 27, 2017By Elaine Siegfried M.D.
There is no doubt that living with distinguishing physical features can be difficult. More than one study has ranked chronic skin disease as a condition with the greatest negative impact on a child’s quality of life. The expert words of medical providers can have a significant impact on these essential concerns.I prescribe compounded medications. Can I be sued?
October 03, 2017By David J. Goldberg M.D. J.D.
Dr. Skin has a large dermatology practice and treats a variety of medical and cosmetic conditions. He has studied and lectured extensively on the topic of rosacea. He understands much of the pathophysiology of rosacea. He begins to use a copycat version of a compounded topical, which he has been able to get at a discounted rate. Unfortunately several patients have severe reactions, and he is soon the recipient of multiple medical malpractice lawsuits. Has he done anything wrong?Clinical Dermatology
Dermatologists collaborate on data-driven pediatric psoriasis research
August 08, 2017By Lisette Hilton
A global community of physicians cooperated to share experiences with systemic drugs for pediatric psoriasis, and to get experience with a joint registry. A uniform dataset could be tapped to learn more about disease manifestations and treatment outcomesGene therapy trial for blistering skin condition advancing to next stage
August 31, 2017By Lisette Hilton
FCX-007 could be the first major medical advance for recessive dystrophic epidermolysis bullosa, or RDEB, in decades.
Atopic dermatitis associated with different bacteria depending on disease severity
September 07, 2017By Andrew Bowser
NIH investigators find that Staphylococcus epidermidis is predominant in less severe cases, while Staphylococcus aureus is associated with patients who have more severe disease.Patch testing remains underreported
October 03, 2017By Bob Kronemyer
Patch testing for allergic contact dermatitis in the pediatric population is performed at a higher rate than previously reported, but still grossly underreported, according to a study of the Pediatric Contact Dermatitis Registry.Propranolol equal to steroids in infantile hemangioma treatment
October 03, 2017By Bob Kronemyer
Prednisolone was the first-line therapy for hemangiomas for many years before propranolol was recognized as the treatment of choice in infantile hemangiomas. Both modalities have a 90% response rate.The neonatal microbiome
October 03, 2017By Lisette Hilton
Cesarean section newborns have a slightly delayed microbiome response. The richness of microorganisms is less than vaginally delivered newborns by 3-7 days. Use products on neonatal skin that are designed for neonatal skin.Cosmetic Dermatology
Data support panfacial aesthetics approach
October 04, 2017By John Jesitus
The HARMONY study puts objective data behind the aesthetic and psychological improvements delivered by a panfacial approach to facial rejuvenation. It’s also the first study to use video analysis, and online photo ratings from a representative sample of Americans, as outcome measures.Proven steps to enhance the aesthetic consult
October 04, 2017By Lisette Hilton
The consult can make or break your success. Listen to and question concerns. Show you care.The concerns around phthalates
October 01, 2017By Zoe Diana Draelos M.D.
One of the most concerning group of chemicals are phthalates, which are used as plasticizers to increase the flexibility, transparency, durability and longevity of plasticsHealth concerns with BPA
October 07, 2017By Zoe Diana Draelos M.D.
BPA is found in food containers, dental fillings and vitamin gel capsules. It also is found in milk, butter and meats, just like phthalates, and is also considered a hormone disruptor.Cutaneous Oncology
The many faces of melanoma
August 15, 2017By Ilya Petrou M.D
Beginning this week, we will publish a series of case studies and quizzes on the subtypes and features of melanoma.Case study: 20 non-melanomas and now this mysterious lesion
August 15, 2017By Eve J. Lowenstein M.D. Ph.D., Kavita Darji M.D.
In this case, the clinical diagnosis can be difficult as the features of the lesion overlap in this 90-year-old patient. What is the diagnosis?Superficial spreading in lentigo maligna
August 23, 2017By Eve J. Lowenstein M.D. Ph.D., Kavita Darji M.D.
A 61-year-old white female with a past medical history of atrial fibrillation presents with a brown spot on her right ear of unknown duration. What wouldn’t you do during the first office visit?Melanoma quiz: Diagnosis, differential and black patches
August 23, 2017By Kavita Darji M.D., Eve J. Lowenstein M.D. Ph.D.
71-year-old Caucasian woman presents with an asymptomatic 4 cm x 2.5 cm black patch.Case presentation: Subungual melanoma
August 29, 2017By Kavita Darji M.D., Eve J. Lowenstein M.D. Ph.D.
A Caucasian female presented with a dark brown band on her nail that appeared a few years ago signifying subungual melanoma. What is the most concerning symptom?Quiz: Acral lentiginous melanoma
August 29, 2017By Kavita Darji M.D., Eve J. Lowenstein M.D. Ph.D.
In this installment of our melanoma case studies series, we focus on factors associated with acral lentiginous melanoma.FDA expands ipilimumab approval to pediatric melanoma
July 25, 2017
The US Food and Drug Administration (FDA) has expanded the approval of ipilimumab (Yervoy) to include the treatment of pediatric melanoma patients 12 years and older with unresectable or metastatic disease.Changing moles in teens
October 04, 2017By Bob Kronemyer
Mole count in adolescents predictor of melanoma. Sun exposure habits develop in teen years. Prevent melanoma through sun protection. Reduce the number of unnecessary biopsies.
Table of the Month
Considerations for laser treatment in pediatric patients
November 06, 2017
From psychosocial considerations to pain control, in pediatrics, there are a special set of factors physicians should consider before treating these young patients. Reference our table for insights.Articles
Sonidegib gets a new label for recurring laBCC
October 01, 2017By Sarah Thuerk
Sun Pharmaceutical Industries announced in September the FDA has approved a new label for sonidegib (Odomzo, Novartis), an oral hedgehog inhibitor indicated for the treatment of adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or for patients who are not candidates for surgery or radiation therapy.